Evidence map›Paper›PMID 34831089›Full record

ArticleCells2021

Differential Stimulation of Pluripotent Stem Cell-Derived Human Microglia Leads to Exosomal Proteomic Changes Affecting Neurons.

Anna Mallach, Johan Gobom, Charles Arber, Thomas M Piers, John Hardy, Selina Wray, Henrik Zetterberg, Jennifer Pocock

Open access · goldAbstract read
In one paragraph

Article in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Increased circulating TREM2Brain, behavior, & immunity - health · 2026
    Article
  4. Article
  5. Roles of TREM2 in Alzheimer's disease.Translational neurodegeneration · 2025
    Review
  6. Familial Alzheimer's disease mutation identifies novel role of SORLA in release of neurotrophic exosomes.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Anna MallachDepartment of Neuroinflammation, UCL Queen Square Institute of Neurology, University College, London WC1N 1PJ, UK.ORCID 0000-0001-7181-3429
Johan GobomDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, S-43180 Molndal, Sweden.
Charles ArberDepartment of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London WC1N 1PJ, UK.ORCID 0000-0002-9743-8134
Thomas M PiersDepartment of Neuroinflammation, UCL Queen Square Institute of Neurology, University College, London WC1N 1PJ, UK.ORCID 0000-0003-1015-3417
John HardyDepartment of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London WC1N 1PJ, UK.
Selina WrayDepartment of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London WC1N 1PJ, UK.ORCID 0000-0003-3062-7050
Henrik ZetterbergDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, S-43180 Molndal, Sweden.
Jennifer PocockDepartment of Neuroinflammation, UCL Queen Square Institute of Neurology, University College, London WC1N 1PJ, UK.ORCID 0000-0001-5812-9331
National Hospital for Neurology and Neurosurgery · GBSahlgrenska University Hospital · SEUK Dementia Research Institute · GB

Funding

Alzheimer Drug Discovery Foundation (ADDF), USA 201809-2016862Alzheimer's Research UK ARUK-SRF2016B-2Biotechnology and Biological Sciences Research Council BB/M009513/1European Research Council 681712Innovative Medicines Initiative 2 Joint Undertaking grant agreement No 115976. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation program and EFPIA. 115976Medical Research Council G0701075Medical Research Council G0901254Medical Research Council G1001253Medical Research Council MR/J004758/1Medical Research Council MR/K01417X/1Medical Research Council MR/L501542/1National Institute for Health Research University College London Hospitals Biomedical Research CentreParkinson's UK G-0907Parkinson's UK G-1307the Swedish state under the agreement between the Swedish government and the County Councils, the ALF-agreement ALFGBG-720931Wallenberg Scholar supported by grants from the Swedish Research Council 2018-02532
6 · The paper itself

Abstract

Microglial exosomes are an emerging communication pathway, implicated in fulfilling homeostatic microglial functions and transmitting neurodegenerative signals. Gene variants of

Indexed as

ProteomicsCell LineExosomesHumansInduced Pluripotent Stem CellsInflammationMicrogliaNeuronsProteomeProteomeAlzheimer’s diseasedementiaexosomesintercellular signallingmicrogliaproteome

Identifiers

PMID34831089
PMCPMC8616378
OpenAlexW3208193332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.